Perceptive Advisors’s Collegium Pharmaceutical COLL Stock Holding History

Perceptive Advisors’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-978,277	Closed	-$23.1M	–	144
2021 Q2	$23.1M	Hold	978,277	–	–	0.3%	78
2021 Q1	$23.2M	Sell	978,277 -1,079,791	-52%	-$25.7M	0.29%	74
2020 Q4	$41.2M	Hold	2,058,068	–	–	0.44%	53
2020 Q3	$42.8M	Hold	2,058,068	–	–	0.63%	42
2020 Q2	$36M	Buy	2,058,068 +506,346	+33%	+$9.91M	0.58%	41
2020 Q1	$25.3M	Buy	1,551,722 +1,130,450	+268%	+$23.3M	0.66%	38
2019 Q4	$8.67M	Buy	+421,272	New	+$7.02M	0.17%	70
2019 Q1	–	Sell	-445,000	Closed	-$7.37M	–	111
2018 Q4	$7.37M	Buy	+445,000	New	+$7.61M	0.28%	57
2018 Q3	–	Sell	-24,213	Closed	-$577K	–	123
2018 Q2	$577K	Buy	+24,213	New	+$595K	0.02%	107
2017 Q1	–	Sell	-196,728	Closed	-$3.06M	–	172
2016 Q4	$3.06M	Buy	+196,728	New	+$3.27M	0.22%	70

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Perceptive Advisors's COLL Position: Q3 2021 in Review

Perceptive Advisors sold out of Collegium Pharmaceutical (COLL) in Q3 2021, closing a stake of 978,277 shares — an estimated $23.1M sold.

Perceptive Advisors first reported a position in COLL in Q4 2016 and held it in 10 quarters. The position peaked at $42.8M in Q3 2020. 154 funds tracked by Wall St. Rank hold COLL as of Q3 2021.

Perceptive Advisors reported no remaining Collegium Pharmaceutical position as of Q3 2021 after selling out during the quarter.
Perceptive Advisors sold 978,277 Collegium Pharmaceutical shares in Q3 2021, an estimated $23.1M.
Perceptive Advisors first reported a position in Collegium Pharmaceutical in Q4 2016 and held it in 10 quarters.
Perceptive Advisors's Collegium Pharmaceutical position peaked at $42.8M in Q3 2020.
154 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2021.

Based on Perceptive Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.